VJOncology is committed to improving our service to you

WCCS/EADO 2016 | The future of cutaneous T-cell lymphoma treatment

VJOncology is committed to improving our service to you

Larisa Geskin

Larisa Geskin, MD of Columbia University Medical Center, New York, NY discusses the future of the treatment of cutaneous T-cell lymphoma (CTCL) at the 2016 World Congress on Cancers of the Skin (WCCS) and the Congress of the European Association of Dermato-Oncology (EADO) in Vienna, Austria. According to Dr Geskin, traditional chemotherapy will give way to targeted therapies and here is a focus on genetic abnormalities and pathway abnormalities in order to find targets. In the future, CTCL will be treated with a personalized approach using antibodies or small molecules.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter